Strouse Counseling And Wellness Llc Counselor Medicare: Not Enrolled in Medicare Practice Location: 137 Montgomery Ave Ste 203, Boyertown, PA 19512 Phone: 610-523-9007 Fax: 610-561-4016 |
Lifegrowth Psychological Services Psychologist Medicare: Not Enrolled in Medicare Practice Location: 137 Montgomery Ave, Suite 105, Boyertown, PA 19512 Phone: 610-473-0277 |
Creative Health Services Inc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Fifth Street And Montgomer, Boyertown Professional Center, Boyertown, PA 19512 Phone: 610-369-7271 Fax: 610-369-7299 |
Sunshine Counseling, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1093 Douglass Dr Apt A, Boyertown, PA 19512 Phone: 610-401-1349 |
Master Your Emotions Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 94 Glendale Rd, Boyertown, PA 19512 Phone: 267-265-1278 Fax: 267-389-2785 |
Sacred Ground, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1291 Reading Ave, Boyertown, PA 19512 Phone: 484-529-3856 |
News Archive
Scientists have revealed the complicated clonal evolution of chronic lymphocytic leukemia, giving insight into the variation in disease course and its response to treatment.
When infections occur in the body, stem cells in the blood often jump into action by multiplying and differentiating into mature immune cells that can fight off illness. But repeated infections and inflammation can deplete these cell populations, potentially leading to the development of serious blood conditions such as cancer.
Compared with non-drinkers, men who consumed at least seven drinks per week during adolescence had three times the odds of being diagnosed with clinically significant prostate cancer.
Vertex Pharmaceuticals Incorporated today announced positive interim results from an ongoing Phase 2 study designed to evaluate the safety and tolerability of INCIVEK (telaprevir) tablets in combination with pegylated-interferon and ribavirin in people who are co-infected with chronic genotype 1 hepatitis C (HCV) and human immunodeficiency virus.
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago